Sanofi US News

"AF Stat(TM) Call to Action for Atrial Fibrillation" Report Cites Limited Understanding, Disconnected Dialogue and Uncoordinated Care as Key Barriers to Improved Outcomes

Influenza A (H1N1) 2009 Monovalent Vaccine licensure a key U.S. milestone in preparing for pandemic response this Fall

Approval Includes Use in Patients Two Years and Older with Seasonal Nasal Allergies Which Affect Forty Percent of Children in the U.S.

New York City Proclaims August 20, 2009 “Pertussis Awareness Day”

- Prophylaxis with Lovenox® (enoxaparin sodium injection) offered a cost reduction per discharge -

Company responds to FDA recommendation for influenza virus strain change supplement

Early shipment of vaccine to assist public health in immunization planning

Leading international experts conclude that these analyses present inconclusive and conflicting data

Multaq(R) approved to reduce the risk of cardiovascular hospitalization in patients with atrial fibrillation or atrial flutter - - U.S. commercial launch planned for the summer of 2009

The CDC Reinstates Booster Dose of Hib Vaccine

Christopher A. Viehbacher Reaffirmed Sanofi-aventis’ Commitment to Access to Health during the Pacific Health Summit in Seattle

A1C and FBG Results for Patients 65 and Under Treated with Lantus and NPH were Similar

Study Presented at 69th Annual ADA Scientific Sessions Examined Efficacy and Safety of Basal-Prandial Treatment with Lantus(R) and Apidra(R)

Company to take first steps toward large-scale production

Initial U.S. order for bulk vaccine valued at $190 million

Sanofi Pasteur committed to increasing its seasonal and pandemic influenza preparedness

Sanofi-aventis and its vaccines division Sanofi Pasteur pursue pandemic preparedness plan in response to WHO Phase 4 influenza pandemic alert

Singer, actress and mother teams up with the March of Dimes and sanofi pasteur to launch national whooping cough education campaign

Swiftwater site project hailed for environmental protection and responsible economic development benefits

Web Site Teams Up with AnnaLynne McCord and Dr. Jeanine Downie to Provide Skin Care Tips and Expert Advice to Look and Feel Your Best by Prom Night

Ben Vereen to Extend National Diabetes Awareness Campaign in Six Additional Cities

Interdisciplinary team of experts joins forces to discuss the latest tools to combat this preventable but deadly disease

Development and Commercialization for Cetrorelix Pamoate in Benign Prostatic Hyperplasia

Apidra(R) SoloSTAR(R) is a Convenient Insulin Delivery Device to Help Patients with Diabetes Improve Glycemic Control

Multaq(R) (dronedarone) significantly reduced the risk of cardiovascular hospitalization or death by 24 percent in patients with atrial fibrillation

Team Type 1 Expands Its Roster, Fielding Five Teams to Spread Personal Messages of Successful Diabetes Management to People Living with Type 1 and Type 2 Diabetes

"KidCare Kit" offers quick-reference materials and multimedia tools to guide families through the first 30 days following a child's diagnosis

Sanofi-aventis U.S. Establishes 'Diabetes National Alliance' of Healthcare Professionals to Help Meet Needs of Growing Diabetes Epidemic in U.S.

The Sanofi-Aventis U.S. Community Health Partnership - It's In Our Hands - Has Been Designed To Help Improve Patient Care By Connecting Patients And Caregivers To Healthcare Resources And Services In Local Communities

The Sanofi-Aventis U.S. Community Health Partnership - It’s In Our Hands - Has Been Designed To Help Improve Patient Care By Connecting Patients And Caregivers To Healthcare Resources And Services In Local Communities